Enfusion Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Operating Revenue	193.86	173.29	148.69	110.38	77.99	58.26
Other Revenue	1.3	1.24	1.66	1.32	1.58	0.77
Revenue	195.16	174.54	150.35	111.7	79.57	59.03
Revenue Growth (YoY)	15.78%	16.09%	34.60%	40.39%	34.79%	-
Cost of Revenue	64.1	57.64	47.1	31.85	21.36	16.96
Gross Profit	131.06	116.89	103.25	79.86	58.21	42.07
Selling, General & Admin	94.5	85.05	98.05	202.34	45.82	24.05
Research & Development	25.35	19.89	17.16	153.4	6.32	4.15
Operating Expenses	119.85	104.95	115.21	355.74	52.13	28.2
Operating Income	11.21	11.95	-11.96	-275.88	6.07	13.87
Interest Expense	-	-	-	-4.59	-1.66	-0.72
Interest & Investment Income	1.6	1.64	0.41	-	-	-
Currency Exchange Gain (Loss)	-	-	-	-	-	-0
Other Non Operating Income (Expenses)	-1.27	-2.11	-0.64	-1.19	0.08	-
Pretax Income	7.11	11.48	-12.19	-281.66	4.49	13.14
Income Tax Expense	2.47	2.23	1.07	0.58	0.43	0.49
Earnings From Continuing Operations	4.64	9.25	-13.26	-282.24	4.06	12.66
Minority Interest in Earnings	-1.32	-3.23	5.61	123.93	-	-
Net Income	3.33	6.03	-7.65	-158.32	4.06	12.66
Preferred Dividends & Other Adjustments	0.6	0.31	0.95	29.47	-	-
Net Income to Common	2.73	5.72	-8.61	-187.79	4.06	12.66
Net Income Growth	-43.61%	-	-	-	-67.91%	-
Shares Outstanding (Basic)	91	88	85	83	0	-
Shares Outstanding (Diluted)	129	129	85	83	0	-
Shares Change (YoY)	7.71%	51.57%	2.83%	173025.83%	-	-
EPS (Basic)	0.03	0.06	-0.10	-2.26	84.66	-
EPS (Diluted)	0.03	0.06	-0.10	-2.26	84.66	-
Free Cash Flow	27.65	21.18	10.17	-6.41	-3.4	7.88
Free Cash Flow Per Share	0.21	0.16	0.12	-0.08	-70.94	-
Gross Margin	67.15%	66.97%	68.67%	71.49%	73.16%	71.27%
Operating Margin	5.74%	6.85%	-7.96%	-246.99%	7.63%	23.50%
Profit Margin	1.40%	3.28%	-5.73%	-168.12%	5.10%	21.44%
Free Cash Flow Margin	14.17%	12.14%	6.76%	-5.74%	-4.28%	13.34%
EBITDA	18.53	18.54	-7.82	-273.21	7.61	14.69
EBITDA Margin	9.49%	10.62%	-5.20%	-244.59%	9.56%	24.89%
D&A For EBITDA	7.32	6.59	4.14	2.68	1.53	0.83
EBIT	11.21	11.95	-11.96	-275.88	6.07	13.87
EBIT Margin	5.74%	6.85%	-7.96%	-246.99%	7.63%	23.50%
Effective Tax Rate	34.71%	19.43%	-	-	9.63%	3.70%
Revenue as Reported	195.16	174.54	150.35	111.7	79.57	59.03
Advertising Expenses	-	1.5	1.5	1.2	1.3	0.46

Source: S&P Capital IQ. Standard template. Financial Sources.